Patents by Inventor Shawn Christopher Miller

Shawn Christopher Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrole derivatives as pharmaceutical agents
    Patent number: 7087626
    Abstract: Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: August 8, 2006
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Todd Vincent DeCollo, Alexander Glenn Godfrey, Theodore Goodson, Jr., Hong-Yu Li, William Thomas McMillen, Shawn Christopher Miller, Jason Scott Sawyer, Edward C. R. Smith, Jonathan Michael Yingling
  • Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
    Patent number: 7045545
    Abstract: The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4?, R5, R5?, and R12 are as described in the specification.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: May 16, 2006
    Assignee: Eli Lilly and Company
    Inventors: Karin Briner, Joseph Paul Burkhart, Timothy Paul Burkholder, Matthew Joseph Fisher, William Harlan Gritton, Daniel Timothy Kohlman, Sidney Xi Liang, Shawn Christopher Miller, Jeffrey Thomas Mullaney, Yao-Chang Xu, Yanping Xu
  • Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
    Patent number: 6967201
    Abstract: The present invention provides serotonergic benzofurylpiperazines of Formula I: where: A is a piperazine of formula: and R, R1, R2, R3, R4, R5, R5?, R6, R6?, R7, R7?, R8, and R8? are as described in the specification.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: November 22, 2005
    Assignee: Eli Lilly and Company
    Inventors: Karin Briner, Joseph Paul Burkhart, Timothy Paul Burkholder, Brian Eugene Cunningham, Matthew Joseph Fisher, William Harlan Gritton, Shawn Christopher Miller, Jeffrey Thomas Mullaney, Matthew Robert Reinhard, Dennis Charles Thompson, Leonard Larry Winneroski, Yanping Xu
  • Serotonergic benzofurans
    Patent number: 6881733
    Abstract: The present invention provides serotonergic benzofurans of Formula (I): where A, R, R1, R2, R3, and R4 are as described in the specification.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: April 19, 2005
    Assignee: Eli Lilly and Company
    Inventors: Karin Briner, Joseph Paul Burkhart, Timothy Paul Burkholder, Brian Eugene Cunningham, Matthew Joseph Fisher, William Harlan Gritton, Cynthia Darshini Jesudason, Shawn Christopher Miller, Jeffrey Thomas Mullaney, Matthew Robert Reinhard, Roger Ryan Rothhaar, Freddie Craig Stevens, Leonard Larry Winneroski, Yanping Xu, Yao-Chang Xu
  • N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
    Publication number: 20040132800
    Abstract: The present invention provides compounds of formula (I), which are antagonists of the 5-HT6 receptor.
    Type: Application
    Filed: February 27, 2004
    Publication date: July 8, 2004
    Inventors: Zhaogen Chen, Michael Philip Cohen, Matthew Joseph Fisher, Bruno Giethlen, James Ronald Gillig, Jefferson Ray McCowan, Shawn Christopher Miller, John Mehnert Schaus
  • Novel pyrrole derivatives as pharmaceutical agents
    Publication number: 20040106604
    Abstract: Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S.
    Type: Application
    Filed: November 6, 2003
    Publication date: June 3, 2004
    Inventors: Douglas Beight, Todd DeCollo, Alexander Glenn Godfrey, Theodore Goodson, Hong-Yu Li, William McMillen, Shawn Christopher Miller, Jason Sawyer, Edward C.R. Smith, Jonathan Michael Yingling
  • Anti-viral compound
    Patent number: 5891874
    Abstract: A series of benzimidazole compounds having the following general structure are provided which inhibit the growth of picornaviruses (e.g., rhinoviruses, enteroviruses, polioviruses, coxsackieviruses of the A and B groups, echo virus and Mengo virus) and flaviviruses (e.g., hepatitis C and bovine diarrheal virus). ##STR1## A method for inhibiting picornaviruses and flaviviruses is also provided which includes administering to a host an effective amount of the inventive benzimidazole compounds.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: April 6, 1999
    Assignee: Eli Lilly and Company
    Inventors: Joseph Matthew Colacino, Beverly Ann Heinz, Louis Nickolaus Jungheim, Shawn Christopher Miller, Wayne Alfred Spitzer, Joseph Chiou-chung Tang, Mark Joseph Tebbe, Frantz Victor
  • Anti-viral compounds
    Patent number: 5821242
    Abstract: The present application provides a series of benzimidazole compounds which inhibit the growth of picornaviruses, such as rhinoviruses, enteroviruses, polioviruses, coxsackieviruses of the A and B groups, echo virus and Mengo virus and flaviviruses such as hepatitis C and bovine diarrheal virus.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: October 13, 1998
    Assignee: Eli Lilly and Company
    Inventors: Joseph Matthew Colacino, Beverly Ann Heinz, Louis Nickolaus Jungheim, Shawn Christopher Miller, Wayne Alfred Spitzer, Joseph Chiou-chung Tang, Mark Joseph Tebbe, Frantz Victor